The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242210 | PMC |
| http://dx.doi.org/10.1016/j.idcr.2020.e00837 | DOI Listing |
Publication Analysis
Top Keywords
treatment severe
4
severe pneumonia
4
covid-19
4
pneumonia covid-19
4
covid-19 peginterferon
4
peginterferon alfa
4
alfa outbreak
4
outbreak coronavirus
4
coronavirus disease
4
disease 2019
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!